How many clinical trials are tracked for palmoplantar pustulosis?

6 trials are tracked, 2 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Palmoplantar pustulosis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for palmoplantar pustulosis

6 trials tracked for palmoplantar pustulosis: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 102 citations.

6Trials tracked

2Phase 3 & 4

0Recruiting

2With published results

Phase distribution

Phase 3 2 Phase 2 4

Phase 3 An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis Completed · 102 cited
Phase 3 Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP) Completed · 5 cited
Phase 2 A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) Completed
Phase 2 Anakinra for Inflammatory Pustular Skin Diseases Completed
Phase 2 Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS) Completed
Phase 2 A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.